pre-seed
Stage
1
Investors
About
Keylika develops AI-enabled drug discovery and nanotechnology-based transdermal delivery systems, including a novel prescription skin patch for treating iron deficiency anemia by enabling direct iron absorption while avoiding gastrointestinal side effects.
Explore Keylika's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.